Detalles de la búsqueda
1.
Association of Preoperative and Postoperative Plasma Syndecan-1 and Colorectal Cancer Outcome.
Anticancer Res;
44(4): 1611-1618, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38537984
2.
Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer.
Oncologist;
2024 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340010
3.
Implication of IZUMO2 in the cell-in-cell phenomenon: A potential therapeutic target for triple-negative breast cancer.
Thorac Cancer;
15(7): 513-518, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38258402
4.
Application of an artificial intelligence-based system in the diagnosis of breast ultrasound images obtained using a smartphone.
World J Surg Oncol;
22(1): 2, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38167161
5.
Patients Offer Radiofrequency Ablation Therapy for Early Breast Cancer as Local Therapy (PO-RAFAELO) Study under the Patient-proposed Health Services.
JMA J;
6(4): 505-512, 2023 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37941717
6.
Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.
J Cancer;
14(14): 2644-2654, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37779870
7.
Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial).
J Immunother Cancer;
11(9)2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37709297
8.
Adiponectin-expressing Treg-containing T cell fraction inhibits tumor growth in orthotopically implanted triple-negative breast cancer.
Thorac Cancer;
14(30): 3058-3062, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37674354
9.
Clinical Possibility of Caenorhabditis elegans as a Novel Evaluation Tool for Esophageal Cancer Patients Receiving Chemotherapy: A Prospective Study.
Cancers (Basel);
15(15)2023 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37568686
10.
Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316).
Breast Cancer;
30(6): 943-951, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37486454
11.
Comprehensive Genome profile testing in head and neck cancer.
Auris Nasus Larynx;
50(6): 952-959, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37164815
12.
Late recurrent gastric carcinoma 12 years after surgery with attenuation of CD44 variant 9 expression.
Surg Case Rep;
9(1): 87, 2023 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37212902
13.
Potential activity of adiponectin-expressing regulatory T cells against triple-negative breast cancer cells through the cell-in-cell phenomenon.
Thorac Cancer;
14(20): 1941-1945, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37220892
14.
Oncofertility-related psycho-educational therapy for young adult patients with breast cancer and their partners: Randomized controlled trial.
Cancer;
129(16): 2568-2580, 2023 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37082910
15.
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients.
Breast Cancer;
30(4): 584-595, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36930419
16.
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1).
Breast Cancer;
30(3): 412-423, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36689066
17.
Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04).
Breast Cancer;
30(2): 293-301, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36609911
18.
Data of programmed death-ligand 1 expression and VEGF: Nivolumab, bevacizumab and paclitaxel For HER2-negative metastatic breast cancer.
Data Brief;
45: 108558, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36118297
19.
The mechanism underlying resistance to 5-fluorouracil and its reversal by the inhibition of thymidine phosphorylase in breast cancer cells.
Oncol Lett;
24(3): 311, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35949616
20.
Gastric carcinosarcoma with FGFR2 amplification under long-term control with pazopanib: a case report and literature review.
BMC Gastroenterol;
22(1): 360, 2022 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35902814